ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $624,451 | +56.9% | 5,113 | +32.8% | 0.04% | +41.4% |
| Q3 2022 | $398,000 | +11.2% | 3,851 | 0.0% | 0.03% | +20.8% |
| Q2 2022 | $358,000 | -20.8% | 3,851 | 0.0% | 0.02% | +4.3% |
| Q1 2022 | $452,000 | +11.3% | 3,851 | +27.6% | 0.02% | -4.2% |
| Q4 2021 | $406,000 | +7.4% | 3,017 | +27.4% | 0.02% | +9.1% |
| Q3 2021 | $378,000 | +21.2% | 2,369 | 0.0% | 0.02% | +10.0% |
| Q2 2021 | $312,000 | +40.5% | 2,369 | +37.6% | 0.02% | +33.3% |
| Q1 2021 | $222,000 | -7.1% | 1,722 | +20.1% | 0.02% | -25.0% |
| Q4 2020 | $239,000 | – | 1,434 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |